Marker Therapeutics, Inc.

Monthly Archives: November 2015

Immuno-Oncology Company, TapImmune Inc., Moves Corporate Headquarters to Jacksonville Florida

…Clinical-Stage Developer of Vaccines for Cancer & Metastatic Disease moves into closer proximity to collaborators at Mayo Clinic in Jacksonville

JACKSONVILLE, Florida, November 5, 2015 /PRNewswire/ –

TapImmune Inc., (TPIV) a clinical-stage immune-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that it has relocated its corporate headquarters from Seattle, Washington, to Jacksonville, Florida, located at 50 North Laura Street, Suite 2500, Jacksonville, Florida 32202.

Read More